Serogroup B meningococcal vaccination practice patterns on college campuses

Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningoco...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2020-10, Vol.38 (46), p.7350-7356
Main Authors: Haimowitz, Rachel, Torres, Rachel, Caleb, Susan, Thompson, Danielle, Smith, Allison, Ciotoli, Carlo, Dannenbaum, Martha, Fu, Linda Y.
Format: Article
Language:English
Subjects:
Antigens
Clinical decision making
Clinical practice guidelines
College
College campuses
College students
Colleges & universities
Decision making
Education
Health care facilities
Humans
Immunization
Male
Meningococcal Infections - epidemiology
Meningococcal Infections - prevention & control
Meningococcal Vaccines
Neisseria meningitidis, Serogroup B
Practice guidelines
Quality control
Quality improvement
Serogroup
Students
United States
Vaccination
Vaccines
Young adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningococcal serogroup B vaccination (MenB) rather than routinely recommend vaccination as with the meningococcal A,C,W,Y vaccine (MenACWY). This study examines the attitudes and practices of HCPs working in college student health centers (SHCs) regarding the recommendation and administration of MenB to students. The study was conducted as an online and phone survey of SHC HCPs from a sample of colleges across the United States between May 2017 and July 2018. Items compared college SHC policies and practices for MenB to those for MenACWY. It also assessed perceived barriers to and facilitators of MenB delivery to students. Among the 147 respondents, almost 50% more reported their SHC stocked and administered MenACWY (54.1%) than MenB (37%) (p = .004). Almost five times as many colleges required their students receive MenACWY as MenB (53.5% vs. 10.5%, p 
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2020.09.035